|  | Multimorbidity | |||
---|---|---|---|---|---|
 |  | OR (95%CI) | |||
Screen-based behaviors | 18 to 34 y | 35 to 49 y | 50 to 64 y | ≥ 65 y | |
Crude | Â | Â | Â | Â | Â |
TV-viewing | < 2 h/d | ref | ref | ref | ref |
 | 2 to < 3 h/d | 0.94 (0.77–1.15) | 1.02 (0.89–1.17) | 1.18 (1.05–1.32) | 1.20 (1.06–1.37) |
 | 3 to < 6 h/d | 1.13 (0.92–1.39) | 1.20 (1.02–1.41) | 1.24 (1.10–1.41) | 1.38 (1.20–1.59) |
 | ≥ 6 h/d | 1.38 (0.99–1.94) | 1.61 (1.27–2.04) | 1.84 (1.52–2.22) | 1.73 (1.43–2.09) |
Other screens | < 2 h/d | ref | ref | ref | ref |
 | 2 to < 3 h/d | 0.88 (0.71–1.10) | 1.05 (0.90–1.22) | 1.00 (0.85–1.17) | 1.15 (0.87–1.52) |
 | 3 to < 6 h/d | 0.97 (0.80–1.18) | 0.98 (0.82–1.17) | 1.14 (0.96–1.36) | 1.81 (1.28–2.54) |
 | ≥ 6 h/d | 1.17 (0.95–1.45) | 0.96 (0.80–1.16) | 1.15 (0.89–1.48) | 1.54 (0.94–2.50) |
Adjusted | Â | Â | |||
TV-viewing | < 2 h/d | ref | ref | ref | ref |
 | 2 to < 3 h/d | 0.94 (0.77–1.15) | 1.03 (0.90–1.17) | 1.17 (1.05–1.32) | 1.20 (1.05–1.37) |
 | 3 to < 6 h/d | 1.14 (0.93–1.41) | 1.20 (1.02–1.40) | 1.22 (1.08–1.39) | 1.36 (1.18–1.56) |
 | ≥ 6 h/d | 1.38 (0.98–1.93) | 1.54 (1.21–1.96) | 1.77 (1.46–2.16) | 1.63 (1.34–1.98) |
Other screens | < 2 h/d | ref | ref | ref | ref |
 | 2 to < 3 h/d | 0.90 (0.73–1.12) | 1.10 (0.94–1.29) | 1.05 (0.89–1.24) | 1.18 (0.88–1.58) |
 | 3 to < 6 h/d | 1.00 (0.81–1.22) | 1.03 (0.86–1.22) | 1.16 (0.97–1.38) | 1.98 (1.42–2.77) |
 | ≥ 6 h/d | 1.20 (0.96–1.50) | 1.02 (0.84–1.23) | 1.16 (0.89–1.52) | 1.73 (1.06–2.84) |